New developments in cyanide antidotes 1.13.1. First aid and treatment measures at the site ofġ.11. Summary of treatment recommendations 1.10.1. Antidotal treatmentġ.9.2.8 Antidotes to methaemoglobin-formingġ.10.
Protective measures for occupational exposure 1.9. Biological detoxification of cyanide 1.7.1. Cyanide concentration in blood and plasma 1.7. Unit, Directorate-General Information Technologies and Industries,ġ. EUR 14280 EN of the Commission of the EuropeanĬommunities, Dissemination of Scientific and Technical Knowledge (c) World Health Organization, Geneva, 1993 and Might be made of the information contained in this report. Neither the Commission of the European Communities nor any personĪcting on behalf of the Commission is responsible for the use which World Health Organization in preference to others of a similar Products does not imply that they are endorsed or recommended by the The mention of specific companies or of certain manufacturers' Organization and of the Commission of the European Communities Published by Cambridge University Press on behalf of the World Health World Health Organization, Geneva, SwitzerlandĬommission of the European Communities, Luxembourgįormerly of the Dutch National Poison Control Centre, International Programme on Chemical Safety, Ulleval University Hospital, Oslo, Norway Practical use to clinical toxicologists and all those involved in theĭepartment of Health, London, United Kingdom The series will thereforeĬollate a wealth of useful information which will be of immense This scientific assessment is complemented byĭetailed clinical information on routes of administration,Ĭontraindications, precautions and so on. Will greatly assist in the selection and administration of anĪppropriate antidote. TheĪim has been to provide an authoritative consensus statement which This series will therefore summarise and assess, on an antidote byĪntidote basis, their clinical use, mode of action and efficacy. Rigorous way the efficacy and use of a wide range of antidotes. To identify and evaluate for the first time in a scientific and Undertaken a major programme to evaluate antidotes used clinically Of the European Communities (CEC) (ILO/UNEP/WHO) have jointly International Programme on Chemical Safety (IPCS) and the Commission Guidance on the use of antidotes to treat poisoning.
This important new series will provide definitive and authoritative Volume 2 Antidotes for poisoning by cyanide Volume 1 Naloxone, flumazenil and dantrolene as antidotes IPCS International Programme on Chemical SafetyĬEC Commission of the European Communities Antidotes for Poisoning by Cyanide IPCS/CEC EVALUATION OF ANTIDOTES SERIES VOLUME 2 ANTIDOTES FOR POISONING BY CYANIDE
0 kommentar(er)
